CZASF yields 19801.98% · PFE yields 6.13%● Live data
📍 CZASF pulled ahead of the other in Year 1
Combined, CZASF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CZASF + PFE for your $10,000?
China ZhengTong Auto Services Holdings Limited, an investment holding company, engages in 4S dealership business in the People's Republic of China. The company operates through 4S Dealership Business, Supply Chain Business, Financial Services Business, and Comprehensive Properties Business segments. It is involved in the sale of motor vehicles and automobile parts; and provision of maintenance and repair services. The company also provides motor-related logistics services; and trades in lubricant oil and auto supplies. In addition, it focuses on the dealership of branded automobiles, including Porsche, BMW, Mercedes-Benz, Audi, Jaguar Land Rover, Hongqi, Volvo, Cadillac, and Infiniti; and operates dealership stores of middle market brands, such as Dongfeng-Nissan, Buick, Dongfeng-Honda, FAW-Volkswagen, Chevrolet, FAW Toyota, and Hyundai. Further, the company engages in the development and sale of real estate properties; property management; trading pre-owned automobiles; e-commerce platform; and provision of consulting and automobile trading agency services, as well as insurance agency services. As of December 31, 2021, it operated 118 dealership outlets in 40 cities across 17 provinces and municipalities. The company was founded in 1999 and is headquartered in Beijing, the People's Republic of China.
Full CZASF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.